Wells Fargo’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6K Hold
31,000
﹤0.01% 5887
2026
Q1
$14.2K Buy
+31,000
New +$28.6K ﹤0.01% 5879
2025
Q3
Sell
-297
Closed -$481 7451
2025
Q2
$481 Sell
297
-17,642
-98% -$28.5K ﹤0.01% 6377
2025
Q1
$21.3K Buy
17,939
+397
+2% +$634 ﹤0.01% 5689
2024
Q4
$36.1K Buy
17,542
+5,009
+40% +$11.7K ﹤0.01% 5587
2024
Q3
$31.7K Buy
12,533
+9,578
+324% +$31.3K ﹤0.01% 5507
2024
Q2
$12.6K Buy
2,955
+2,699
+1,054% +$17.4K ﹤0.01% 5704
2024
Q1
$1.89K Buy
+256
New +$2.15K ﹤0.01% 6043

Other funds holding GUTS

Wells Fargo's GUTS Position: Q2 2026 in Review

Wells Fargo held its Fractyl Health (GUTS) position steady in Q2 2026 at 31,000 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5887.

Wells Fargo first reported a position in GUTS in Q1 2024 and has held it in 8 quarters since. The position peaked at $36.1K in Q4 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Wells Fargo held 31,000 shares of Fractyl Health worth $24.6K as of Q2 2026.
  • Wells Fargo left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5887 holding.
  • Wells Fargo first reported a position in Fractyl Health in Q1 2024 and has held it in 8 quarters since.
  • Wells Fargo's Fractyl Health position peaked at $36.1K in Q4 2024.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.